• 1. Nanoporous organic layered crystals of double-headed bis(trifluorolactate)s. Hydrogen-bonded systematic crystal structures controlled by the symmetries of molecular components
  Satoshi Takahashi,Toshimasa Katagiri,Kenji Uneyama CrystEngComm 2006 8 132
• 2. Catalytic properties of the metal ion variants of mandelate racemase reveal alterations in the apparent electrophilicity of the metal cofactor
  Matthew L. Harty,Amar Nath Sharma,Stephen L. Bearne Metallomics 2019 11 707
• 3. A molecular-sized tunnel-porous crystal with a ratchet gear structure and its one-way guest-molecule transportation property
  Keisuke Kataoka,Tetsuaki Yasumoto,Yousuke Manabe,Hiroyasu Sato,Akihito Yamano,Toshimasa Katagiri Nanoscale 2013 5 1298
• 4. A binary hydrogen bonding motif based on homochiral recognition: crystal structures and hydrogen bonding networks of meso-(R,S)-bis(trifluorolactate)s
  Satoshi Takahashi,Toshimasa Katagiri,Kenji Uneyama Chem. Commun. 2005 3658

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Hydroxy acids and derivatives Alpha hydroxy acids and derivatives

(S)-Trifluorolactic Acid (CAS No. 125995-00-8): A Comprehensive Overview

(S)-Trifluorolactic Acid (CAS No. 125995-00-8) is a chiral compound that has gained significant attention in the fields of organic synthesis, pharmaceutical research, and materials science. This compound is a fluorinated derivative of lactic acid, characterized by its unique chemical structure and properties. The presence of the trifluoromethyl group imparts enhanced stability and reactivity, making it a valuable building block in various synthetic pathways.

The (S)-enantiomer of trifluorolactic acid is particularly important due to its chirality, which plays a crucial role in biological systems and pharmaceutical applications. Chiral molecules are essential in drug design and development, as they can exhibit different biological activities depending on their spatial configuration. The (S)-enantiomer of trifluorolactic acid has been extensively studied for its potential in the synthesis of chiral drugs and intermediates.

Recent advancements in the synthesis of (S)-Trifluorolactic Acid have focused on developing efficient and scalable methods. One notable approach involves the use of asymmetric catalysis, which allows for the selective production of the desired enantiomer with high enantiomeric excess (ee). For example, a study published in the Journal of Organic Chemistry reported a highly efficient asymmetric hydrogenation method using a ruthenium catalyst, achieving an ee value of over 99%.

In the context of pharmaceutical research, (S)-Trifluorolactic Acid has shown promise as a key intermediate in the synthesis of several important drugs. Its unique properties, such as increased metabolic stability and improved pharmacokinetic profiles, make it an attractive candidate for drug development. For instance, it has been used in the synthesis of antiviral agents, anticancer drugs, and anti-inflammatory compounds.

The biological activity of (S)-Trifluorolactic Acid has also been explored in various studies. Research has shown that this compound can modulate specific biological pathways, making it a potential lead compound for drug discovery. A study published in Bioorganic & Medicinal Chemistry Letters demonstrated that derivatives of (S)-Trifluorolactic Acid exhibit potent inhibitory activity against certain enzymes involved in cancer progression.

In addition to its pharmaceutical applications, (S)-Trifluorolactic Acid has found use in materials science. Its fluorinated nature imparts unique physical properties, such as low surface energy and high thermal stability. These properties make it suitable for applications in coatings, polymers, and other advanced materials. For example, it has been used to synthesize fluoroelastomers with improved mechanical properties and chemical resistance.

The environmental impact of (S)-Trifluorolactic Acid is another area of interest. While fluorinated compounds can be persistent in the environment, recent studies have focused on developing more sustainable synthetic methods to minimize environmental concerns. Green chemistry principles are being applied to optimize the production process, reducing waste and energy consumption.

In conclusion, (S)-Trifluorolactic Acid (CAS No. 125995-00-8) is a versatile compound with significant potential in multiple fields. Its unique chemical properties and chirality make it an important building block in organic synthesis and pharmaceutical research. Ongoing research continues to uncover new applications and improve synthetic methods, further highlighting its importance in modern chemistry.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)